Reflect Scientific, Inc. (RSCF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -459.02 Thousand USD | -613.48% |
| 2022 | 89.39 Thousand USD | -90.48% |
| 2021 | 939.06 Thousand USD | 42.26% |
| 2020 | 660.11 Thousand USD | 436.21% |
| 2019 | -196.34 Thousand USD | 21.31% |
| 2018 | -249.52 Thousand USD | 37.96% |
| 2017 | -402.18 Thousand USD | -86.03% |
| 2016 | -216.19 Thousand USD | -125.86% |
| 2015 | 835.93 Thousand USD | 199.42% |
| 2014 | -840.8 Thousand USD | 17.01% |
| 2013 | -1.01 Million USD | -604.29% |
| 2012 | 200.91 Thousand USD | 116.93% |
| 2011 | -1.18 Million USD | 33.02% |
| 2010 | -1.77 Million USD | 63.7% |
| 2009 | -4.88 Million USD | -125.55% |
| 2008 | -2.16 Million USD | 69.41% |
| 2007 | -7.07 Million USD | -623.11% |
| 2006 | -978.63 Thousand USD | -2664.34% |
| 2005 | 38.16 Thousand USD | -10.47% |
| 2004 | 42.62 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 108.98 Thousand USD | 440.89% |
| 2024 Q1 | -31.97 Thousand USD | 85.22% |
| 2023 Q3 | 86.26 Thousand USD | 147.64% |
| 2023 FY | -459.02 Thousand USD | -613.48% |
| 2023 Q4 | -216.36 Thousand USD | -350.82% |
| 2023 Q2 | -181.08 Thousand USD | -22.49% |
| 2023 Q1 | -147.83 Thousand USD | -141.13% |
| 2022 Q1 | 206.5 Thousand USD | -42.74% |
| 2022 FY | 89.39 Thousand USD | -90.48% |
| 2022 Q2 | 78.12 Thousand USD | -62.17% |
| 2022 Q3 | -133.92 Thousand USD | -271.42% |
| 2022 Q4 | -61.31 Thousand USD | 54.22% |
| 2021 Q4 | 360.62 Thousand USD | 125.55% |
| 2021 Q3 | 159.88 Thousand USD | -6.38% |
| 2021 Q2 | 170.78 Thousand USD | -31.07% |
| 2021 Q1 | 247.76 Thousand USD | -21.54% |
| 2021 FY | 939.06 Thousand USD | 42.26% |
| 2020 Q3 | 204.18 Thousand USD | 902.18% |
| 2020 Q1 | 165.59 Thousand USD | 195.53% |
| 2020 FY | 660.11 Thousand USD | 436.21% |
| 2020 Q2 | -25.45 Thousand USD | -115.37% |
| 2020 Q4 | 315.78 Thousand USD | 54.65% |
| 2019 Q2 | -18.23 Thousand USD | -229.36% |
| 2019 Q3 | 1521.00 USD | 108.34% |
| 2019 Q4 | -173.34 Thousand USD | -11496.71% |
| 2019 FY | -196.34 Thousand USD | 21.31% |
| 2019 Q1 | -5535.00 USD | 93.7% |
| 2018 FY | -249.52 Thousand USD | 37.96% |
| 2018 Q4 | -87.92 Thousand USD | -106.53% |
| 2018 Q3 | -42.57 Thousand USD | 80.45% |
| 2018 Q2 | -217.74 Thousand USD | -320.57% |
| 2018 Q1 | 98.72 Thousand USD | 120.92% |
| 2017 Q1 | -2388.00 USD | 99.16% |
| 2017 FY | -402.18 Thousand USD | -86.03% |
| 2017 Q4 | -471.95 Thousand USD | -899.15% |
| 2017 Q3 | 59.05 Thousand USD | 350.85% |
| 2017 Q2 | 13.09 Thousand USD | 648.53% |
| 2016 FY | -216.19 Thousand USD | -125.86% |
| 2016 Q1 | 35.89 Thousand USD | 109.84% |
| 2016 Q4 | -283.96 Thousand USD | -468.83% |
| 2016 Q3 | -49.92 Thousand USD | -161.03% |
| 2016 Q2 | 81.79 Thousand USD | 127.9% |
| 2015 Q1 | -31.27 Thousand USD | 96.01% |
| 2015 FY | 835.93 Thousand USD | 199.42% |
| 2015 Q4 | -364.6 Thousand USD | -689.34% |
| 2015 Q3 | -46.19 Thousand USD | -103.61% |
| 2015 Q2 | 1.27 Million USD | 4186.36% |
| 2014 Q3 | -64.32 Thousand USD | -232.21% |
| 2014 FY | -840.8 Thousand USD | 17.01% |
| 2014 Q4 | -783.21 Thousand USD | -1117.65% |
| 2014 Q2 | -19.36 Thousand USD | -174.2% |
| 2014 Q1 | 26.09 Thousand USD | 103.39% |
| 2013 Q2 | -87.67 Thousand USD | 21.12% |
| 2013 Q4 | -768.92 Thousand USD | -1591.83% |
| 2013 Q1 | -111.15 Thousand USD | 95.75% |
| 2013 Q3 | -45.44 Thousand USD | 48.16% |
| 2013 FY | -1.01 Million USD | -604.29% |
| 2012 Q3 | 3.28 Million USD | 1642.57% |
| 2012 Q4 | -2.61 Million USD | -179.51% |
| 2012 FY | 200.91 Thousand USD | 116.93% |
| 2012 Q1 | -259.29 Thousand USD | 37.97% |
| 2012 Q2 | -213 Thousand USD | 17.85% |
| 2011 Q2 | -390.55 Thousand USD | -103.17% |
| 2011 Q4 | -418.02 Thousand USD | -124.55% |
| 2011 Q3 | -186.16 Thousand USD | 52.33% |
| 2011 Q1 | -192.23 Thousand USD | 6.25% |
| 2011 FY | -1.18 Million USD | 33.02% |
| 2010 Q1 | -1.31 Million USD | 16.73% |
| 2010 FY | -1.77 Million USD | 63.7% |
| 2010 Q4 | -205.04 Thousand USD | -68.09% |
| 2010 Q3 | -121.98 Thousand USD | 7.6% |
| 2010 Q2 | -132.01 Thousand USD | 89.95% |
| 2009 Q3 | -932.58 Thousand USD | 35.44% |
| 2009 FY | -4.88 Million USD | -125.55% |
| 2009 Q1 | -927.71 Thousand USD | 29.18% |
| 2009 Q2 | -1.44 Million USD | -55.72% |
| 2009 Q4 | -1.57 Million USD | -69.1% |
| 2008 Q3 | -169.54 Thousand USD | 4.36% |
| 2008 Q2 | -177.26 Thousand USD | 65.08% |
| 2008 Q4 | -1.3 Million USD | -672.64% |
| 2008 Q1 | -507.62 Thousand USD | 88.87% |
| 2008 FY | -2.16 Million USD | 69.41% |
| 2007 Q4 | -4.55 Million USD | -313.42% |
| 2007 FY | -7.07 Million USD | -623.11% |
| 2007 Q1 | -397.35 Thousand USD | -353.68% |
| 2007 Q2 | -1.01 Million USD | -156.04% |
| 2007 Q3 | -1.1 Million USD | -8.39% |
| 2006 Q3 | -774.81 Thousand USD | -435.59% |
| 2006 Q1 | 24.26 Thousand USD | 499.21% |
| 2006 Q4 | -87.58 Thousand USD | 88.7% |
| 2006 FY | -978.63 Thousand USD | -2664.34% |
| 2006 Q2 | -144.66 Thousand USD | -696.31% |
| 2005 Q4 | -6077.00 USD | -110.97% |
| 2005 FY | 38.16 Thousand USD | -10.47% |
| 2005 Q3 | 55.41 Thousand USD | 3537.78% |
| 2005 Q1 | -9564.00 USD | 0.0% |
| 2005 Q2 | -1612.00 USD | 83.15% |
| 2004 FY | 42.62 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 50.477% |
| Ansell Limited | 76.5 Million USD | 100.6% |
| Ansell Limited | 76.5 Million USD | 100.6% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 101.891% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 71.843% |
| Psykey, Inc. | -1.32 Million USD | 65.329% |
| ConvaTec Group Plc | 130.3 Million USD | 100.352% |
| ConvaTec Group Plc | 130.3 Million USD | 100.352% |
| Encision Inc. | -691.78 Thousand USD | 33.646% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -223.69% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -95.859% |
| Innovative MedTech Inc. | -7.93 Million USD | 94.218% |
| LifePoint, Inc. | -15.23 Million USD | 96.986% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 93.26% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 3.159% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -67.256% |
| SmileDirectClub, Inc. | -86.4 Million USD | 99.469% |
| Sector 10, Inc. | 7036.00 USD | 6623.991% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.023% |
| SheerVision, Inc. | -71.37 Thousand USD | -543.113% |
| United Health Products, Inc. | -2.62 Million USD | 82.502% |
| Vasamed, Inc. | -4.88 Million USD | 90.609% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 80.781% |
| Yubo International Biotech Limited | -1.2 Million USD | 61.899% |